Key result
Serum myoglobin determination did not offer any clinical advantage over creatine kinase MB isoenzyme for the early diagnosis of acute myocardial infarction.
Why the study?
Does serum myoglobin offer a clinical advantage over CK MB in the early diagnosis of acute myocardial infarction in patients admitted to a coronary care unit?
Observational (n=109)
Does serum myoglobin offer a clinical advantage over CK MB in the early diagnosis of acute myocardial infarction in patients admitted to a coronary care unit?
Serum myoglobin does not offer any clinical advantage over CK MB as an early indicator of acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Myoglobin adds no early diagnostic value over CK-MB in AMI; leaves open relevance with high-sensitivity troponin in contemporary cohorts.
We compared the clinical usefulness of serum myoglobin and creatine kinase MB (CK MB) isoenzyme determinations in the early diagnosis of acute myocardial infarction in 109 consecutive patients admitted to a coronary care unit. Of these, 37 patients were diagnosed as having definite infarction, three possible infarction, and 69 no infarction, using World Heath Organisation criteria. Blood samples were taken on admission and two to four hours later, Both CK MB and myoglobin were raised in the initial serum samples in 24 of the 37 patients with definite infarction. In an additional seven patients both CK MB and myoglobin were negative in the first specimen though both were detected in the second sample. In five patients CK MB preceded the appearance of myoglobin while in the remaining patient myoglobin appeared before CK MB. We conclude that the detection of serum myoglobin does not offer any clinical advantage over CK MG as an early indicator of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Freeman et al. (1981) conducted an observational in Acute myocardial infarction (n=109). Serum myoglobin determination vs. Creatine kinase MB (CK MB) isoenzyme determination was evaluated on Early diagnosis of acute myocardial infarction. Serum myoglobin determination did not offer any clinical advantage over creatine kinase MB isoenzyme for the early diagnosis of acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: